Implementing a new antimicrobial stewardship policy in urology significantly reduced antibiotic use by over 60% and costs by 20%. Patient care quality remained high, with fewer patients treated overall.
Urological wards often exhibit high antimicrobial consumption rates.
Effective stewardship programs are crucial for optimizing patient outcomes and resource management.
Purpose of the Study:
To develop and implement a comprehensive antimicrobial use policy for a urological ward.
To evaluate the impact of this policy on antibiotic consumption, patient care quality, and costs over a four-year period.
To assess the collaborative efforts between Urology and Clinical Pharmacy in antimicrobial stewardship.
Main Methods:
Development and implementation of evidence-based guidelines for rational antimicrobial prescribing.
Prospective monitoring of antimicrobial consumption, patient outcomes (wound infections, adverse events), and associated costs.
Four-year data collection and analysis to assess policy effectiveness.
Interdepartmental collaboration between Urology and Clinical Pharmacy.
Main Results:
Achieved over a 60% reduction in overall antibiotic consumption.
Reduced the number of patients treated with antimicrobials by 50%, with age-dependent variations.
Maintained or improved patient care quality, evidenced by stable rates of postoperative wound infections and adverse effects.
Reported a 20% decrease in antimicrobial-related costs.
Conclusions:
A well-defined antimicrobial stewardship policy, supported by interdisciplinary collaboration, can significantly reduce antibiotic use and costs in urology.
The policy demonstrated effectiveness in optimizing antimicrobial prescribing without compromising patient safety or quality of care.
The findings highlight the importance of continuous monitoring and adaptation of antimicrobial stewardship strategies.
